Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Ginkgo biloba on outcomes of metabolic syndrome
IRCT20200803048285N1Phase 3Completed
- Sponsor
- College of Pharmacy
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ginkgo biloba extract in cardiometabolic risk (CMR), sponsored by College of Pharmacy. Started May 2020; status: completed.
02
Drugs
ginkgo biloba extract
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT20200803048285N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200803048285N1.